CoChat

NEK1 mutations in familial amyotrophic lateral sclerosis

Brenner, David, Müller, Kathrin, Wieland, Thomas, Weydt, Patrick, Böhm, Sarah, Lulé, Dorothée, Hübers, Annemarie, Neuwirth, Christoph, Weber, Markus, Borck, Guntram, Wahlqvist, Magnus, Danzer, Karin M., Volk, Alexander E., Meitinger, Thomas, Strom, Tim M., Otto, Markus, Kassubek, Jan, Ludolph, Albert C., Andersen, Peter M., Weishaupt, Jochen H. · 2016 · Brain
Cited by 146

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Sir, Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by adult-onset loss of motor neurons. Five to 10% of all ALS cases are familial ALS. To date, more than 20 genes have been implicated in causing familial ALS, with the discovery of mutations in CHCHD10 ( Bannwarth et al. , 2014 ) and TBK1 ( Cirulli et al. , 2015 ; Freischmidt et al. , 2015 ) representing the latest examples for monogenic causes of ALS. Most recently, whole exome sequencing of ALS patients suggested an association of heterozygous loss-of-function mutations in NEK1 with ALS. However, this observation was made in a cohort of mostly sporadic patients, and the result was only significant in a combined analysis of the discovery and the replication cohort ( Cirulli et al. , 2015 ), making further validation essential. To assess the association between NEK1 variants and familial ALS we analysed whole exome sequence data of 265 familial ALS index patients and 827 control individuals. A subset of these exome sequence data has recently led to the discovery of mutations in TBK1 as a cause for ALS in an exome-wide mutational burden analysis ( Freischmidt et al. , 2015 ). The patients with familial ALS were selected from families with two or more affected individuals from European countries (Germany, Sweden, Finland, Denmark, Switzerland, and Portugal) following a negative screen for SOD1 and C9orf72 mutations as described previously ( Freischmidt et al. , 2015 ). In-house control exomes ( n = 827) from Germany were used to compare the variant burden in NEK1 . All ALS patients were diagnosed according to the EFNS Consensus criteria ( Andersen et al. , 2012 ). Control subjects were comprised of healthy parents of children with various diseases, healthy control tissues of individuals with tumour diseases and 200 individuals of the KORA study. With informed written consent and approval by the national medical ethical review boards in accordance with the Declaration of Helsinki ( WMA, 2013 ), EDTA blood samples were drawn from control individuals, ALS patients and their healthy relatives. DNA was extracted from EDTA blood samples according to standard procedures ( Erdmann et al. , 2013 ). Sequencing, read mapping and variant calling was performed on HiSeq2000/2500 systems (Illumina) as described previously ( Freischmidt et al. , 2015 ).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/aww033

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 146

Metadata

Authors
Brenner, D., Müller, K., Wieland, T., Weydt, P., Böhm, S., Lulé, D., Hübers, A., Neuwirth, C., Weber, M., Borck, G., Wahlqvist, M., Danzer, K. M., Volk, A. E., Meitinger, T., Strom, T. M., Otto, M., Kassubek, J., Ludolph, A. C., Andersen, P. M., & Weishaupt, J. H.
Venue
Brain
Published
2016-03-05
Volume
139
Issue
5
Pages
e28-e28
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W2288626167
Cited by
146
References
4
FWCI
11.80
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.